ARCHIVES

FDA Approves Bayer’s Xofigo For Late-Stage Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Reauthorization Bill Ready For Senate Floor; Report to Panel Makes Clear Why Renewal Needed

April 22, 1988

MRI Reveals Information That May Alter Treatment

December 28, 2007

HHS Appeals Board Finds No Misconduct By Popovic

November 12, 1993

In Brief: DCBD Board Adds Concept Review To Duties, Rabson Seeks Four Additional Member

September 19, 1980

Search Committee Finishes Job, Submits Choices To Califano

April 15, 1977

Five Year Survival Up To 48 Percent; DeVita Has “No Doubt” It Is Really Over 50 Percent Now

December 2, 1983